APA
HZNP

American Portfolios Advisors’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

American Portfolios Advisors’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$1.6M Sell
25,790
-1,100
-4% -$76.9K 0.07% 295
2022
Q2 		$2.14M Sell
26,890
-704
-3% -$66.7K 0.09% 232
2022
Q1 		$2.9M Buy
27,594
+5,064
+22% +$494K 0.1% 213
2021
Q4 		$2.43M Buy
22,530
+1,346
+6% +$147K 0.08% 246
2021
Q3 		$2.32M Buy
21,184
+494
+2% +$51.3K 0.09% 234
2021
Q2 		$1.94M Buy
20,690
+136
+0.7% +$12.5K 0.08% 269
2021
Q1 		$1.89M Buy
20,554
+399
+2% +$33.7K 0.08% 239
2020
Q4 		$1.47M Buy
20,155
+8
+0% +$595 0.08% 255
2020
Q3 		$1.57M Buy
20,147
+53
+0.3% +$3.65K 0.09% 202
2020
Q2 		$1.12M Buy
20,094
+2,663
+15% +$114K 0.07% 247
2020
Q1 		$516K Sell
17,431
-204
-1% -$6.9K 0.04% 360
2019
Q4 		$638K Sell
17,635
-274
-2% -$8.4K 0.05% 363
2019
Q3 		$488K Sell
17,909
-766
-4% -$19.8K 0.04% 405
2019
Q2 		$449K Buy
18,675
+14,979
+405% +$380K 0.04% 429
2019
Q1 		$97.7K Buy
+3,696
New +$87.6K 0.01% 910

Other funds holding HZNP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

American Portfolios Advisors's HZNP Position: Q3 2022 in Review

American Portfolios Advisors reduced its Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) stake by 4.1% in Q3 2022, selling an estimated $76.9K and leaving 25,790 shares worth $1.6M. The position accounts for 0.07% of the portfolio, ranked #295.

American Portfolios Advisors first reported a position in HZNP in Q1 2019 and has held it in 15 quarters since. The position peaked at $2.9M in Q1 2022. 530 funds tracked by Wall St. Rank hold HZNP as of Q3 2022.

  • American Portfolios Advisors held 25,790 shares of Horizon Therapeutics Public Limited Company Ordinary Shares worth $1.6M as of Q3 2022.
  • American Portfolios Advisors sold 1,100 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q3 2022, an estimated $76.9K.
  • Horizon Therapeutics Public Limited Company Ordinary Shares made up 0.07% of American Portfolios Advisors's portfolio in Q3 2022, its #295 holding.
  • American Portfolios Advisors first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2019 and has held it in 15 quarters since.
  • American Portfolios Advisors's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $2.9M in Q1 2022.
  • 530 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q3 2022.

Based on American Portfolios Advisors's 13F filing for Q3 2022, filed 17 Mar 2023.